Non-alcoholic steatohepatitis is seen in all, except:
All are features of hepatocellular carcinoma, except?
The hepatotoxic octapeptides of Amanita phalloides usually produce which of the following types of liver injury?
A 40-year-old woman dies after a long history of an illness characterized by dyspnea, orthopnea, hepatomegaly, distended neck veins, and peripheral edema. The cut surface of the liver as it appears at autopsy is shown in the image. Which of the following disorders is the most likely cause of these findings?

A 24-year-old patient presented with unexplained weight loss and fever. Routine examinations showed elevated liver function tests. USG showed a growth in the liver which was confirmed as fibrolamellar carcinoma of the liver. What is NOT true about fibrolamellar carcinoma of the liver?
Which of the following zones of the liver lobule is more prone to ischemia?
What differentiates chronic persistent hepatitis from chronic active hepatitis?
Alcoholic hyaline in alcoholic liver disease is composed of?
All of the following are true regarding epithelioid hemangioendothelioma except?
Budd-Chiari syndrome occurs in association with which of the following?
Explanation: **Explanation:** Non-alcoholic fatty liver disease (NAFLD) and its progressive form, **Non-alcoholic steatohepatitis (NASH)**, are fundamentally metabolic disorders characterized by hepatic fat accumulation in the absence of significant alcohol consumption [1]. **Why Gallstone disease is the correct answer:** Gallstone disease (cholelithiasis) is a **complication** or a co-existing condition often seen in patients with metabolic syndrome, but it is not a direct cause or a clinical component of NASH itself. While both share risk factors like obesity, the pathophysiology of NASH is driven by insulin resistance and lipotoxicity, whereas gallstones involve bile stasis and cholesterol supersaturation in the gallbladder. **Analysis of Incorrect Options:** * **Obesity (B):** This is the most common risk factor. Adipose tissue dysfunction leads to an increased flux of free fatty acids to the liver [1]. * **Diabetes Mellitus (A):** Type 2 Diabetes and insulin resistance are central to the "two-hit hypothesis" of NASH [1]. Insulin resistance promotes peripheral lipolysis and hepatic de novo lipogenesis [1]. * **Hypertriglyceridemia (C):** Dyslipidemia (specifically high triglycerides and low HDL) is a core component of Metabolic Syndrome, which is strongly associated with hepatic steatosis [3]. **High-Yield NEET-PG Pearls:** * **Pathogenesis:** The "Two-Hit Hypothesis"—1st hit is steatosis (fat accumulation); 2nd hit is oxidative stress leading to inflammation and fibrosis [1]. * **Histology:** NASH is characterized by the triad of **Steatosis, Ballooning degeneration** of hepatocytes, and **Mallory-Denk bodies** [2]. * **Most common cause:** Metabolic Syndrome (Obesity, T2DM, Hypertension, Dyslipidemia) [3]. * **Other causes to remember:** Total parenteral nutrition (TPN), rapid weight loss, and drugs like Amiodarone or Methotrexate. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 851-852. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 852-854. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 389-390.
Explanation: ### Explanation **1. Why Option A is the Correct Answer (The "Except" Feature):** Hepatocellular Carcinoma (HCC) is **highly prevalent in Asian populations**, particularly in East and Southeast Asia [1], [3]. This is primarily due to the high endemicity of **Hepatitis B Virus (HBV)** and exposure to **Aflatoxin B1** (produced by *Aspergillus flavus*) [1]. Therefore, stating it is "not common" in Asians is factually incorrect, making it the right choice for an "except" question. **2. Analysis of Other Options:** * **Option B (Liver biopsy is diagnostic):** Histopathology remains the gold standard for diagnosis. It typically shows a trabecular pattern, bile production by tumor cells, and Mallory-Denk bodies [1]. However, in clinical practice, imaging (LI-RADS criteria) is often used to avoid the risk of needle track seeding. * **Option C (Raised titre of HBV and HCV antibodies):** Chronic viral hepatitis is the leading cause of HCC globally [1]. HBV (a DNA virus) integrates into the host genome, while HCV (an RNA virus) causes chronic inflammation and cirrhosis, both significantly increasing HCC risk [1], [3]. * **Option D (Fibrolamellar type has a good prognosis):** This is a distinct variant of HCC occurring in young adults (20–40 years) without underlying cirrhosis. It is characterized by "onocytic" hepatocytes separated by parallel lamellae of collagen. It has a significantly better prognosis than conventional HCC. **3. Clinical Pearls for NEET-PG:** * **Tumor Marker:** **Alpha-fetoprotein (AFP)** is the most common marker; levels >400 ng/mL are highly suggestive [2]. * **Most common site of metastasis:** Intrahepatic (within the liver) and extrahepatic to the **Lungs** [4]. * **Molecular Pathogenesis:** Mutations in **TP53** (associated with Aflatoxin) and **CTNNB1** (Beta-catenin) are common [1]. * **Gross Appearance:** Can be unifocal (massive), multifocal, or diffusely infiltrative [5]. It has a strong propensity for **vascular invasion** (portal and hepatic veins) [5]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 876-877. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 399-400. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 215-216. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 879-880. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 878-879.
Explanation: **Explanation:** The correct answer is **Massive hepatic necrosis (Option A)**. *Amanita phalloides*, commonly known as the "Death Cap" mushroom, contains potent hepatotoxic octapeptides called **amatoxins** (specifically **α-amanitin**). The underlying mechanism involves the inhibition of **RNA polymerase II**, which halts mRNA synthesis and leads to widespread cell death. Because the toxin is potent and systemic, it causes extensive, pan-lobular destruction of hepatocytes, leading to a "shrunken" liver and acute liver failure—a classic example of massive hepatic necrosis [1]. **Analysis of Incorrect Options:** * **B. Centrilobular zonal necrosis (Zone 3):** This is typically seen in ischemic injury or toxicities requiring metabolic activation by the P450 system (e.g., **Paracetamol/Acetaminophen** poisoning or Carbon tetrachloride) [1]. While *Amanita* can affect Zone 3, its primary hallmark is the progression to massive, non-zonal necrosis. * **C. Periportal injury (Zone 1):** This is characteristic of toxins that do not require metabolic activation or are directly toxic upon entering the liver via the portal vein, such as **Phosphorus** poisoning or Eclampsia. * **D. Granuloma formation:** This is a chronic inflammatory response seen in conditions like Sarcoidosis, Tuberculosis, or drug reactions (e.g., Allopurinol), not in acute fulminant poisoning [2]. **High-Yield Facts for NEET-PG:** * **Mechanism:** α-amanitin inhibits RNA Polymerase II. * **Clinical Course:** Characterized by a "latent period" (6–24 hours) followed by severe GI symptoms and subsequent fulminant hepatic failure. * **Morphology:** The liver appears small, shrunken, and bile-stained with a wrinkled capsule [1]. * **Other causes of Massive Necrosis:** Viral hepatitis (HBV, HEV in pregnancy), drugs (Halothane, Isoniazid), and heatstroke [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 832. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 401-402.
Explanation: ***Right-sided heart failure*** - The clinical presentation of **dyspnea, orthopnea, hepatomegaly, distended neck veins, and peripheral edema** represents classic signs of **congestive heart failure** with systemic venous congestion. - The liver findings show **chronic passive hepatic congestion** (nutmeg liver appearance) with **centrilobular congestion and necrosis**, pathognomonic for right-sided heart failure causing hepatic venous congestion. *Chronic alcoholism* - Would typically present with **hepatic steatosis** progressing to **alcoholic hepatitis** and eventually **cirrhosis** with regenerative nodules. - Lacks the **centrilobular congestion pattern** and **nutmeg appearance** seen in cardiac hepatopathy; patients would have history of alcohol abuse rather than heart failure symptoms. *Diabetes mellitus* - Associated with **non-alcoholic fatty liver disease (NAFLD)** showing **macrovesicular steatosis** without the congestion pattern. - Does not cause the **systemic venous congestion** signs like distended neck veins and peripheral edema; hepatomegaly would be due to fatty infiltration, not congestion. *Niemann-Pick disease* - A **lysosomal storage disorder** characterized by **foamy lipid-laden macrophages** (Niemann-Pick cells) in liver and other organs. - Typically presents in **infancy or childhood** with hepatosplenomegaly and neurological symptoms, not adult-onset heart failure with venous congestion.
Explanation: **Explanation:** Fibrolamellar Carcinoma (FLC) is a distinct variant of Hepatocellular Carcinoma (HCC) that differs significantly from conventional HCC in its clinical presentation and biochemical profile. **Why Option D is the correct answer:** The hallmark of Fibrolamellar Carcinoma is that **Alpha-Fetoprotein (AFP) levels are typically normal.** Unlike conventional HCC, where AFP is a sensitive tumor marker [1], FLC does not produce AFP. Therefore, an AFP level > 1000 ng/mL is highly characteristic of conventional HCC or yolk sac tumors, but NOT FLC. Instead, FLC may show elevated serum neurotensin or vitamin B12-binding capacity. **Analysis of other options:** * **Option A (More common in females):** FLC shows a slight female predilection or an equal gender distribution (M:F = 1:1), unlike conventional HCC which is significantly more common in males. * **Option B (Occurs in younger individuals):** FLC typically affects adolescents and young adults (usually between 5–35 years of age), whereas conventional HCC usually occurs in older patients with underlying cirrhosis [1]. * **Option C (Better prognosis):** FLC generally has a better prognosis than conventional HCC because it usually arises in a **non-cirrhotic liver**, allowing for better surgical resectability [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Morphology:** Characterized by large, polygonal cells with abundant eosinophilic cytoplasm (due to mitochondria) and prominent nucleoli, separated by **parallel lamellae of collagen bundles**. * **Gross Appearance:** Often presents as a single large hard mass with a **central stellate scar** (mimicking Focal Nodular Hyperplasia). * **Genetic Marker:** A characteristic **DNAJB1-PRKACA fusion gene** resulting from a deletion on chromosome 19 is highly specific for FLC. * **Risk Factors:** It is NOT associated with HBV, HCV, or cirrhosis [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 399-400.
Explanation: The liver is organized into functional units called **hepatic acini**, which are divided into three zones based on their proximity to the blood supply (the portal triad) [3]. **1. Why Zone 3 (Centrilobular) is the correct answer:** Zone 3 is the area surrounding the central vein. It is the **farthest** from the hepatic artery and portal vein [3]. Consequently, the blood reaching this zone has the lowest oxygen tension and nutrient concentration. Because it sits at the "distal end" of the blood flow, it is the first to suffer from hypoxia and is most susceptible to **ischemic injury** (e.g., shock liver) and **nutmeg liver** (congestive heart failure) [1, 2]. Additionally, it contains the highest concentration of CYP450 enzymes, making it the primary site for drug-induced injury (e.g., Paracetamol toxicity). **2. Why other options are incorrect:** * **Option A (Periportal/Zone 1):** This zone is closest to the portal triad and receives the most oxygenated blood. It is the most resistant to ischemia but is the first to be affected by direct-acting toxins (e.g., phosphorus) and viral hepatitis. * **Option B (Midzonal/Zone 2):** This is the intermediate area. While it can be affected, it is rarely the primary site of injury except in specific conditions like Yellow Fever. * **Option D:** The zones have distinct metabolic and vascular profiles [3]; therefore, they are never affected equally by systemic insults. **High-Yield Clinical Pearls for NEET-PG:** * **Ischemia/Shock/Right Heart Failure:** Affects Zone 3 (Centrilobular necrosis) [1]. * **Paracetamol (Acetaminophen) Toxicity:** Affects Zone 3 (due to NAPQI formation by CYP450). * **Aflatoxin/Hepatitis:** Primarily affects Zone 1. * **Yellow Fever:** Classically affects Zone 2 (Councilman bodies). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 870-872. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 401-402. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 828.
Explanation: The distinction between chronic persistent hepatitis (CPH) and chronic active hepatitis (CAH) is fundamentally based on **histopathological architecture**, making a liver biopsy the definitive diagnostic tool. [1] ### **Explanation of the Correct Answer** While both conditions involve chronic inflammation of the liver (lasting >6 months), they are differentiated by the **location and extent of inflammation** seen on biopsy: * **Chronic Persistent Hepatitis (CPH):** Inflammation is strictly confined to the **portal tracts**. The limiting plate (the layer of hepatocytes bordering the portal tract) remains intact. It carries a good prognosis and rarely progresses to cirrhosis. * **Chronic Active Hepatitis (CAH):** Characterized by **"piecemeal necrosis"** (interface hepatitis), where inflammation spills over the portal tract into the surrounding parenchyma, destroying the limiting plate. [1] This form is aggressive and frequently progresses to cirrhosis. ### **Why Other Options are Incorrect** * **Anti-SM and Autoantibodies (A & C):** These are markers used to diagnose **Autoimmune Hepatitis**, not to differentiate the morphological patterns of CPH vs. CAH. [2] While CAH is often associated with autoimmune markers, these antibodies do not define the "activity" or "persistence" of the hepatitis; only histology can. * **C-reactive protein (B):** CRP is a non-specific acute-phase reactant. It indicates general systemic inflammation but provides no information regarding liver architecture or the specific type of hepatitis. ### **NEET-PG High-Yield Pearls** * **Interface Hepatitis:** The hallmark of Chronic Active Hepatitis (formerly called piecemeal necrosis). [1] * **Ground Glass Hepatocytes:** Seen in Chronic Hepatitis B (due to HBsAg accumulation in the ER). [1] * **Councilman Bodies:** Eosinophilic apoptotic hepatocytes seen in acute viral hepatitis (and Yellow Fever). * **Bridging Necrosis:** A feature of severe CAH where necrosis connects portal-to-portal or portal-to-central vein areas. [1] **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 843-844. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 845-846.
Explanation: **Explanation:** The correct answer is **B. Eosinophilic intracytoplasmic inclusions.** **Understanding Alcoholic Hyaline (Mallory-Denk Bodies):** Alcoholic hyaline, also known as **Mallory-Denk bodies**, are characteristic morphological features of alcoholic hepatitis [1]. Microscopically, they appear as irregular, ropey, **eosinophilic (pink-staining)** clumps within the cytoplasm of hepatocytes [2]. Biochemically, these inclusions are composed of tangled masses of **intermediate filaments**, specifically **Pre-keratin (Cytokeratin 8 and 18)**, complexed with other proteins like ubiquitin and p62. They are typically found in "ballooned" (swollen) hepatocytes and are often surrounded by neutrophils (satellitosis) [1]. **Why other options are incorrect:** * **A. Lipofuscin:** This is a "wear-and-tear" pigment representing lipid peroxidation. It appears as golden-brown granular pigment, not eosinophilic hyaline. * **C. Basophilic intracytoplasmic inclusions:** Basophilic (blue/purple) inclusions are not characteristic of alcoholic liver disease. Examples of basophilic structures include Negri bodies (though these are eosinophilic, they are often confused) or certain viral inclusions like CMV (which are often amphophilic). * **D. Hemozoin:** This is a malarial pigment formed by the breakdown of hemoglobin by *Plasmodium* parasites. **High-Yield Clinical Pearls for NEET-PG:** * **Mallory-Denk bodies** are NOT pathognomonic for alcoholic liver disease; they are also seen in **Wilson disease, Non-alcoholic steatohepatitis (NASH), Primary Biliary Cholangitis (PBC), and Indian Childhood Cirrhosis.** * **Stain:** They can be highlighted using **Ubiquitin** immunohistochemical stains. * **Reversibility:** Fatty change (steatosis) is the earliest and most reversible stage of alcoholic liver disease [1]. * **Classic Triad of Alcoholic Hepatitis:** Hepatocyte swelling (ballooning), Mallory bodies, and Neutrophilic infiltration [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 389-390. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 388-389. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 852-854.
Explanation: **Explanation:** **Epithelioid Hemangioendothelioma (EHE)** is a rare vascular neoplasm of intermediate malignancy, falling between a benign hemangioma and a highly aggressive angiosarcoma. 1. **Why Option A is the correct answer (The Exception):** Unlike many other primary liver tumors, EHE shows a distinct **female preponderance** (Female:Male ratio of approximately 3:1). Therefore, the statement that it is "most common in males" is incorrect. 2. **Analysis of other options:** * **Option B (Liver Transplant):** EHE is unique because, despite being a malignant tumor that is often multicentric or metastatic at presentation, it has a relatively indolent course. Liver transplantation is considered a standard and effective treatment of choice for unresectable cases, showing excellent long-term survival rates. * **Option C (Vinyl Chloride):** While more classically associated with hepatic Angiosarcoma, exposure to vinyl chloride, oral contraceptives, and asbestos has also been implicated in the pathogenesis of EHE. * **Option D (Factor VIII Staining):** Since EHE is a tumor of endothelial origin, it expresses vascular markers [1]. **Factor VIII-related antigen**, CD31, and CD34 are used immunohistochemically to confirm the diagnosis [1]. **NEET-PG High-Yield Pearls:** * **Characteristic Histology:** Features "epithelioid" endothelial cells with intracytoplasmic vacuoles (containing RBCs) and a myxoid/sclerotic stroma. * **Molecular Marker:** The **WWTR1-CAMTA1** gene fusion is a highly specific diagnostic marker for EHE. * **Radiology:** Often presents as peripheral subcapsular nodules that may cause "capsular retraction." **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 527-528.
Explanation: **Explanation:** **Budd-Chiari Syndrome (BCS)** is a clinical triad of abdominal pain, ascites, and hepatomegaly caused by the obstruction of hepatic venous outflow [1]. This obstruction can occur at any level from the small hepatic veins to the junction of the inferior vena cava (IVC) with the right atrium. The underlying pathophysiology is almost always related to a **hypercoagulable state** (thrombophilia). 1. **Antithrombin III deficiency (Option A):** Antithrombin is a natural anticoagulant. Its deficiency leads to an unchecked coagulation cascade, significantly increasing the risk of venous thrombosis, including the hepatic veins. 2. **Protein C deficiency (Option B):** Protein C (along with Protein S) acts to inactivate Factors Va and VIIIa. A deficiency removes this "brake" on the system, leading to a prothrombotic state. 3. **Oral Contraceptive (OCP) use (Option C):** Estrogen in OCPs increases the plasma concentration of clotting factors and decreases anticoagulant levels. OCP use is a well-documented acquired risk factor for BCS, especially in women with underlying genetic predispositions [1]. Since all three conditions promote thrombosis, **Option D (All of the above)** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause:** Polycythemia Vera (Myeloproliferative neoplasms) is the most frequent underlying cause of BCS. * **Nutmeg Liver:** Chronic venous congestion leads to a characteristic "nutmeg" appearance of the liver (centrilobular congestion and necrosis) [1]. * **Caudate Lobe Hypertrophy:** Because the caudate lobe has independent venous drainage directly into the IVC, it often undergoes compensatory hypertrophy in BCS. * **Clinical Presentation:** Patients typically present with the triad of **hepatomegaly, ascites, and abdominal pain.** **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 869-870.
Jaundice and Cholestasis
Practice Questions
Viral Hepatitis
Practice Questions
Alcoholic and Non-alcoholic Fatty Liver Disease
Practice Questions
Drug and Toxin Induced Liver Injury
Practice Questions
Cirrhosis and Its Complications
Practice Questions
Metabolic Liver Diseases
Practice Questions
Liver Tumors
Practice Questions
Gallbladder and Biliary Tract Diseases
Practice Questions
Congenital Liver Diseases
Practice Questions
Liver Transplantation Pathology
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free